Maxim Group Starts Radiopharm Theranostics (RADX) at Buy
Tweet
Share
E-mailGet Alerts RADX Hot Sheet
Price: $2.56 -3.4%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Maxim Group analyst Michael Okunewitch initiates coverage on Radiopharm Theranostics (NASDAQ: RADX) with a Buy rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Radiopharm Theranostics click here. For more ratings news on Radiopharm Theranostics click here.
Shares of Radiopharm Theranostics closed at $3.91 yesterday.
You May Also Be Interested In
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- BMO Capital Starts Energy Fuels (UUUU) at Outperform
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
